D. E. Shaw & Co., Inc. Aspira Women'S Health Inc. Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $241,247 - $657,398	-603,118 Reduced 87.18%	88,709 $52,000
Q1 2022 May 16, 2022	BUY	$0.88 - $1.81 $74,862 - $153,978	85,071 Added 14.02%	691,827 $720,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $541,073 - $1.14 Million	331,947 Added 120.79%	606,756 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $661,105 - $1.14 Million	207,243 Added 306.73%	274,809 $893,000
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $322,965 - $462,151	67,566 New	67,566 $380,000

Q1 2021 May 17, 2021	SELL	$5.9 - $9.13 $176,404 - $272,977	-29,899 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.71 $89,697 - $200,622	29,899 New	29,899 $201,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $185M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.